Development and Applications of Patient‐Derived Xenograft Models in Humanized Mice for Oncology and Immune‐Oncology Drug Discovery
Authors:
Open Access
- 1 September 2017
- journal article
- unit
- Published by Wiley in Current Protocols in Pharmacology
- Vol. 78 (1) , 14.41.1-14.41.12
Abstract
With the recent approval of four novel immune oncology agents for the treatment of various cancers, the emerging power of this drug class has been substantiated. However, the full potential of such agents is yet to be realized, with only a fraction of the patient population responding to these drugs. A more advanced pre‐clinical and translational research platform may increase our understanding of the mechanisms associated with immune‐mediated cancer cell death, thereby facilitating the design and development of more generally efficacious agents and drug regimens. Described in this report are the nuances, advantages, and limitations of such a research approach. © 2017 by John Wiley & Sons, Inc.Keywords
This publication has 23 references indexed in Scilit:
- Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory PhenotypePLOS ONE, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Melanoma drug wins US approvalNature, 2011
- Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnullhumanized miceProceedings of the National Academy of Sciences, 2010
- Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient miceNature Protocols, 2009
- Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/γc−/−, Balb/c-Rag1−/−γc−/−, and C.B-17-scid/bg immunodeficient miceHuman Immunology, 2009
- Creation of “Humanized” Mice to Study Human ImmunityCurrent Protocols in Immunology, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Comparative biology of mouse versus human cells: modelling human cancer in miceNature Reviews Cancer, 2003
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986